From March 26, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on March 27, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.18 CNY | -0.52% | -3.30% | -7.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.39% | 7.72B | |
+41.86% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.99% | 246B | |
+0.61% | 225B | |
+10.66% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Tranche Update on Shanghai Fosun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2024.